AI in Neuro-Oncology: A Review in Neuroimaging.
Authors
Affiliations (49)
Affiliations (49)
- Institute of Neuroscience and Medicine (INM-4), Research Center Juelich (FZJ), Juelich, Germany.
- Department of Nuclear Medicine, RWTH Aachen University Hospital, Aachen, Germany.
- Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN, USA.
- Indiana University Simon Comprehensive Cancer Center, Indiana University, Indianapolis, IN, USA.
- Department of Radiology, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
- Department of Radiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
- Department of Bioengineering, School of Engineering, Santa Clara University, Santa Clara, CA, USA.
- Department of Neurosurgery, Mass General Brigham, Harvard Medical School, Boston, Massachusetts, USA.
- School of Biomedical Engineering & Imaging Sciences, King's College London, London, UK.
- Department of Neuroradiology, Ruskin Wing, King's College Hospital NHS Foundation Trust, London, UK.
- Department of Radiology, Duke University Medical Center, Durham, NC, USA.
- Chair of Imaging and Computer Vision, RWTH Aachen University, Aachen, Germany.
- Center for AI and Data Science for Integrated Diagnostics, University of Pennsylvania, Philadelphia, USA.
- UCLA Brain Tumor Imaging Laboratory, Department of Radiological Sciences, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.
- Department of Radiology, Mayo Clinic, Rochester, Minnesota, USA.
- Radiology Informatics Lab, Department of Radiology, Mayo Clinic, 200 1st Street SW, Rochester, Minnesota, USA.
- Center for Data-Driven Discovery in Biomedicine (D3b), The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
- Department of Neurosurgery, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
- Department of Neurosurgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
- Department of Neurology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
- Institute of Neuroscience and Medicine (INM-3), Research Center Juelich, Juelich, Germany.
- Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD), Aachen, Germany.
- Weill Cornell Medicine, New York, NY, USA.
- Department of Radiology, New York University Grossman School of Medicine, New York, NY, USA.
- Department of Radiation Oncology, Brigham and Women's Hospital and Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.
- Artificial Intelligence in Medicine Program, Mass General Brigham, Boston, Massachusetts, USA.
- Boston Children's Hospital, Boston, Massachusetts, USA.
- Department of Neurosurgery, TUM University Hospital, Technical University of Munich, Munich, Germany.
- Department of Radiation Oncology, Duke University Medical Center, Durham, NC, USA.
- Sheikh Zayed Institute for Pediatric Surgical Innovation, Children's National Hospital, Washington DC, USA.
- School of Medicine and Health Sciences, George Washington University, Washington DC, USA.
- Department of Radiology & Biomedical, University of California San Francisco, San Francisco, CA, USA.
- Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.
- Department of Radiology and Research Institute of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
- Department of Radiology and Imaging Sciences, Indiana University School of Medicine, Indianapolis, IN, USA.
- Department of Machine Learning, Moffitt Cancer Center & Research Institute, Tampa, FL, USA.
- Department of Neuro-Oncology, Moffitt Cancer Center & Research Institute, Tampa, FL, USA.
- Department of Diagnostic Imaging and Interventional Radiology, Moffitt Cancer Center & Research Institute, Tampa, FL, USA.
- Department of Oncologic Sciences, University of South Florida, Tampa, FL, USA.
- Center for Neuro-Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
- Division of Adult Palliative Care, Department of Supportive Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
- Department of Radiology, Mass General Brigham, Harvard Medical School, Boston, MA, USA.
- Department of Radiology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.
- William S. Middleton Memorial Veterans Affairs (VA) Healthcare, Madison, Wisconsin, USA.
- Departments of Radiology & Biomedical Imaging and Neurosurgery, University of California San Francisco, San Francisco, CA, USA.
- Division for Computational Radiology & Clinical AI (CCIBonn.ai), Clinic for Neuroradiology, University Hospital Bonn, Bonn, Germany.
- Division of Medical Image Computing, German Cancer Research Center, Heidelberg, Germany.
- AI for Image-Guided Diagnosis and Therapy, School of Medicine and Health, Technical University of Munich, Munich, Germany.
- Department of Computer Science, Luddy School of Informatics Computing and Engineering, Indiana University, Indianapolis, IN, USA.
Abstract
Artificial intelligence (AI) has become central to neuro-oncological imaging, impacting clinical and scientific workflows. In clinical practice, AI-based image reconstruction and noise reduction expedite the generation of advanced multiparametric MRI and PET scans. Automated segmentation and volumetric analysis improve reproducibility, speed, and standardization of tumor quantification and response assessment. In research, large language and multimodal models extract structured information from radiology reports and medical records. Collaborative initiatives, such as BraTS and FeTS, have established standardized, privacy-compliant frameworks for large-scale quantitative analyses. Tumor-specific applications include noninvasive molecular profiling in gliomas, grading and recurrence prediction in meningiomas, detection and response assessment in brain metastases, and pediatric-specific modeling aligned with RAPNO. However, AI models remain sensitive to technical and biological variations across institutions, limiting their clinical utility unless appropriate training and validation is performed. Nevertheless, progress is evident in prospective, biopsy-validated infiltration mapping, assessment of resection extent aligned with RANO-Resect, and standardization through AI-RANO. Emerging directions include foundation models, uncertainty estimation, federated learning, AI-enhanced ultra-low-field MRI, and dual-tracer PET. When used as a decision-support tool rather than a replacement for the imaging team, AI can increasingly improve the utility, reproducibility, and efficiency of quantitative, multiparametric imaging in patients with brain tumors.